CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
55 hedge funds and large institutions have $126M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
0.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
22
Reduced
11
Closed
13
Calls
$443K
Puts
$580K
Net Calls
-$137K
Net Calls Change
-$690K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.61M |
| 2 |
Morgan Stanley
New York
|
+$3.17M |
| 3 |
Two Sigma Advisers
New York
|
+$1.19M |
| 4 |
Two Sigma Investments
New York
|
+$826K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$646K |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$5.82M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$3.59M |
| 3 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$966K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$773K |
| 5 |
Renaissance Technologies
New York
|
-$548K |
